SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

27 Jan 2025 Evaluate
The sales moved up 36.84% to Rs. 6452.40 millions for the December 2024 quarter as compared to Rs. 4715.20 millions during the year-ago period.Net Profit for the quarter ended December 2024 zoomed to 109.98% from Rs. 493.10 millions to Rs. 1035.40  millions.Operating profit for the quarter ended December 2024 rose to 1863.70 millions as compared to 1252.30 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 6452.40 4715.20 36.84 19225.00 14045.60 36.88 19291.92 21884.00 -11.84
Other Income 38.60 24.60 56.91 118.10 49.80 137.15 65.15 79.84 -18.40
PBIDT 1863.70 1252.30 48.82 5491.50 3308.00 66.01 4877.26 6969.81 -30.02
Interest -0.70 201.90 -100.35 415.00 597.90 -30.59 734.89 655.02 12.19
PBDT 1864.40 1050.40 77.49 5076.50 2710.10 87.32 4142.37 6314.79 -34.40
Depreciation 329.10 308.80 6.57 986.10 931.90 5.82 1235.64 1089.53 13.41
PBT 1535.30 741.60 107.03 4090.40 1778.20 130.03 2906.73 5225.26 -44.37
TAX 499.90 248.50 101.17 1389.60 587.00 136.73 948.84 1691.69 -43.91
Deferred Tax 119.50 112.70 6.03 558.30 259.30 115.31 421.74 748.61 -43.66
PAT 1035.40 493.10 109.98 2700.80 1191.20 126.73 1957.89 3533.57 -44.59
Equity 431.40 415.50 3.83 431.40 415.50 3.83 415.50 415.50 0.00
PBIDTM(%) 28.88 26.56 8.75 28.56 23.55 21.28 25.28 31.85 -20.62

Epigral Share Price

1187.85 18.55 (1.59%)
22-Apr-2026 13:14 View Price Chart
Peers
Company Name CMP
BASF India 3745.10
Tata Chemicals 710.00
SRF 2493.70
Pidilite Inds. 1411.30
Deepak Nitrite 1720.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×